Day: March 8, 2022

Posted on

Chairman PPP Bilawal Bhutto Zardari’s message on International Women’s Day 

Karachi, March 07, 2022 (PPI-OT):Chairman Pakistan Peoples Party Bilawal Bhutto Zardari has said that his Party had been struggling for gender equality and had taken practical steps to ensure that women are provided equal opportunities in every field. In his message on the eve of International Women’s Day being observed across the world under the aegis of the United Nations, the PPP Chairman endorsed its 2022 theme “Gender equality today for a sustainable tomorrow”.

He pointed out that Pakistan elected a woman Shaheed Mohtarma Benazir Bhutto as Prime Minister for the first time in the entire Muslim world. PPP had proudly inducted women judges in the superior courts, elected Speaker and Deputy Speaker in the National Assembly of Pakistan. Shaheed Mohtarma Benazir Bhutto established First Women Bank, separate police stations for women, a network of lady health workers, and allotted land to landless women. PPP was also responsible for introducing pro women legislation including that for harassment of women in the workplace, he said.

Bilawal Bhutto Zardari said that PPP was proud to have the most vibrant Women Wing having organisational network down to the Union Council level. This speaks the level of commitment of the Party towards promotion and empowerment of women. PPP government in Sindh has started a unique programme for economic empowerment of women, which has benefitted nearly a million.

He further pointed out that Benazir Income Support Programme (BISP) was launched by President Asif Ali Zardari in 2008 as an unconditional cash transfer targeted at the millions of poorest women. BISP is an internationally acclaimed programme. Chairman PPP Bilawal Bhutto Zardari pledged that PPP would continue to strive for emancipation and empowerment of women by carving out more opportunities for them in every sector to achieve the dream of Prime Minister Shaheed Mohtarma Benazir Bhutto.

For more information, contact:
PPP Media Cell (Sindh)
Pakistan People’s Party (PPP)
Peoples Secretariat Shikarpur Colony,
Behind Mazar-e-Quaid-e-Azam, Karachi, Pakistan
Cell: +92-305-3370383
Email: contact@ppp-tu.com
Website: https://www.ppp.org.pk

Posted on

Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022

Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022

Mont-Saint-Guibert, Belgium – March 7, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will showcase data from its BETTER SLEEP clinical trial in a poster presentation and host physician events at the 16th World Sleep Congress 2022, which is being held March 11-16 in Rome, Italy. World Sleep, a global scientific congress, gathers leaders in sleep medicine and research from around the world for scientific sessions and networking.

On Monday, March 14 at 5:30pm CET, BETTER SLEEP study data will be presented during a poster session.

Nyxoah will also host two other physician events on Sunday, March 13. In the morning, members of Nyxoah’s clinical and R&D teams will host a scientific advisory board session with a group of U.S. and international key opinion leaders. At 7:00pm CET that evening, Nyxoah will host an event for physicians entitled “Shifting Paradigm in OSA Therapy with Genio”. Nyxoah expects approximately 40 physicians from the U.S. and Europe to attend this event.

“We are proud to participate in the World Sleep Congress and to showcase Genio and our strong clinical data to this global community of KOLs,” said Olivier Taelman, Chief Executive Officer of Nyxoah. “We are also excited to be able to offer Genio to CCC patients in Europe, and having received Breakthrough Device Designation from the U.S. FDA, we are working hard to secure an IDE approval to conduct a clinical trial for CCC patients in the U.S.”

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment